Skip to main content
Information for...
General Use Patients or Carers Health Care Professionals in the US Health Care Professionals outside the US Journalists Jobseekers
  • Press
  • Contact
  • Global sites
Home
  • About Us
    • Corporate Profile
      • Our Company
      • Vision & Values
      • History
      • Diversity & Inclusion
      • Ethics & Compliance
      • Sustainability
      • Making More Health
      • Access to Healthcare
    • Press
      • Press Releases
      • Image Mediapool
      • Events & Initiatives
      • Media Contacts
      • Annual Press Conference
    • Global Activities
      • Europe
      • North America
      • South America
      • Asia
      • Africa
      • Australasia
  • Products
  • Innovation
    • Research & Development
      • Research Approach
      • Research Beyond Borders
      • Drug Discovery
      • Open Innovation
    • Clinical Trials
      • Overview
    • Therapeutic Areas
      • CardioMetabolic
      • CNS
      • Immunology & Respiratory
      • Oncology
    • Boehringer Ingelheim Venture Fund
  • Partnering
    • Our Approach
      • Overview
      • What We Offer
    • Partnering Interests
      • Overview
    • How We Engage
      • Overview
    • News & Communications
      • Press Releases
      • Events
      • Partnering Newsletter
      • Contact Us
  • Human Pharma
    • Cardiovascular
      • Stroke Prevention
      • Acute Ischaemic Stroke
      • DVT/PE
      • Reversal of Anti-coagulation
      • Myocardial Infarction
      • Hypertension
    • Oncology
      • Lung Cancer
    • Respiratory
      • Asthma
      • COPD
      • IPF
      • Scleroderma
    • Central Nervous System
      • Overview
    • Metabolic Diseases
      • Diabetes
      • IntroDia
    • Immunology
      • Overview
  • Animal Health
    • Home
    • About Animal Health Business Unit
    • Livestock
    • Companion Animals
    • Our Responsibility
    • Press Releases
  • Biopharma
  • Careers

Search form

  • Home:
  • Prescription Medicine
  • Telmisartan HCTZ
  • Telmisartan HCTZ
  • About Us
    • Corporate Profile
    • Careers
    • Global Activities
  • Innovation
    • Research
    • Clinical Trials
    • Therapeutic Areas
    • Boehringer Ingelheim Venture Fund
  • Human Pharma
    • Cardiovascular
    • Oncology
    • Respiratory
    • Central Nervous System
    • Metabolic Diseases
    • Immunology
  • Business Units
    • Prescription Medicine
    • Animal Health
  • Global Activities
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • Share
  • Back To Top
  • Facebook
  • Twitter
  • Youtube
  • Linkedin
  • Instagram
  • Pinterest
  • Rss
  • Accessibility Statement
  • Terms of Use
  • Data Privacy
  • Imprint
© 2010-2018 Boehringer Ingelheim International GmbH. All rights reserved.